Lazard Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.3M | Sell |
|
|||||
|
2025
Q1 | $8.01M | Buy |
|
|||||
|
2024
Q4 | $8.33M | Buy |
|
|||||
|
2024
Q3 | $4.62M | Buy |
|
|||||
|
2024
Q2 | $4.67M | Sell |
|
|||||
|
2024
Q1 | $4.9M | Sell |
|
|||||
|
2023
Q4 | $6.5M | Sell |
|
|||||
|
2023
Q3 | $6.64M | Buy |
|
|||||
|
2023
Q2 | $4.2M | Sell |
|
|||||
|
2023
Q1 | $4.28M | Sell |
|
|||||
|
2022
Q4 | $4.33M | Buy |
|
|||||
|
2022
Q3 | $3.76M | Buy |
|
|||||
|
2022
Q2 | $271K | Buy |
|
|||||
|
2022
Q1 | $168K | Sell |
|
|||||
|
2021
Q4 | $1.1M | Buy |
|
|||||
|
2021
Q3 | $1.22M | Buy |
|
|||||
|
2021
Q2 | $2K | Sell |
|
|||||
|
2021
Q1 | $18K | Buy |
|
|||||
|
2020
Q4 | $14K | Sell |
|
|||||
|
2020
Q3 | $439K | Sell |
|
|||||
|
2020
Q2 | $1.99M | Sell |
|
|||||
|
2020
Q1 | $17.5M | Sell |
|
|||||
|
2019
Q4 | $18.4M | Sell |
|
|||||
|
2019
Q3 | $21.6M | Buy |
|
|||||
|
2019
Q2 | $21.3M | Sell |
|
|||||
|
2019
Q1 | $74.7M | Sell |
|
|||||
|
2018
Q4 | $175M | Sell |
|
|||||
|
2018
Q3 | $208M | Sell |
|
|||||
|
2018
Q2 | $200M | Sell |
|
|||||
|
2018
Q1 | $223M | Buy |
|
|||||
|
2017
Q4 | $234M | Sell |
|
|||||
|
2017
Q3 | $245M | Buy |
|
|||||
|
2017
Q2 | $151M | Buy |
|
|||||
|
2017
Q1 | $107M | Buy |
|
|||||
|
2016
Q4 | $371K | Sell |
|
|||||
|
2016
Q3 | $475K | Sell |
|
|||||
|
2016
Q2 | $6.42M | Sell |
|
|||||
|
2016
Q1 | $8.65M | Sell |
|
|||||
|
2015
Q4 | $13M | Buy |
|
|||||
|
2015
Q3 | $9.5M | Sell |
|
|||||
|
2015
Q2 | $15.9M | Sell |
|
|||||
|
2015
Q1 | $18.1M | Sell |
|
|||||
|
2014
Q4 | $19.3M | Buy |
|
|||||
|
2014
Q3 | $18.2M | Buy |
|
|||||
|
2014
Q2 | $12.2M | Buy |
|
|||||
|
2014
Q1 | $3.71M | Sell |
|
|||||
|
2013
Q4 | $5.7M | Sell |
|
|||||
|
2013
Q3 | $4.91M | Hold |
|
|||||
|
2013
Q2 | $4.39M | Buy |
|